A US drug company has created a drug that could slow Alzheimer’s disease, and could soon be available to patients with early signs of the disease. Drug company Biogen said it is seeking regulatory approval for the drug called aducanumab next week after new analysis revealed it had helped reduce the clinical decline of early …
Continue reading “New drug could be a first to slow down the effects of Alzheimer’s disease”